Strong participation of Gustave Roussy at the ESMO 2022 congress
The annual congress of the European Society of Medical Oncology (ESMO) will be held in Paris from September 9 to 13, 2022. This major cancer research event will present the main advances in clinical research. Gustave Roussy is one of the major players in this event and will, at this occasion, announce the launch of its Alumni network.
French and American experts share their knowledge on latest advances and perspectives in Immuno-Oncology
Save the date : Friday the 13th of May 2:30 pm (CEST) for the first online conference dedicated to immuno-oncology set up between the Dana Farber Cancer Institute and Gustave Roussy/Paris-Saclay University.
Breast cancer: a new 5-day course of radiotherapy
Delivering radiotherapy in 5 days instead of 3 to 5 weeks - this is the new challenge taken up by Gustave Roussy. The Institute now offers women over 60, with localised breast cancer, fewer but equally effective radiotherapy sessions after surgery.
Professor Fabrice Barlesi is appointed General Director of Gustave Roussy
By an order, the Minister of Health and Solidarity, Mr. Olivier Véran, appointed Professor Fabrice Barlesi as General Director of Gustave Roussy for a term of five years from 1 August 2021. He succeeds Professor Jean-Charles Soria who will leave his position for family reasons. Professor Barlesi’s appointment ensures that Gustave Roussy will...
Creation of a patient-centered biocluster in oncology
Sanofi, Gustave Roussy, Inserm, Institut Polytechnique de Paris and the University of Paris-Saclay are committed to developing personalized medicine in France through a patient-centered oncology cluster - the Paris Saclay Cancer Cluster.